ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32916-10mg |
|
1426698-88-5 |
Parsaclisib (INCB050465)
|
0 | C20H22ClFN6O2 | |
GC32916-5mg |
|
1426698-88-5 |
Parsaclisib (INCB050465)
|
0 | C20H22ClFN6O2 | |
GC32916-10mM(1mLinDMSO) |
|
1426698-88-5 |
Parsaclisib (INCB050465)
|
0 | C20H22ClFN6O2 | |
GC32915-100mg |
|
1513857-77-6 |
Pemigatinib
|
0 | C24H27F2N5O4 | |
GC32915-50mg |
|
1513857-77-6 |
Pemigatinib
|
0 | C24H27F2N5O4 | |
GC32915-25mg |
|
1513857-77-6 |
Pemigatinib
|
0 | C24H27F2N5O4 | |
GC32915-10mg |
|
1513857-77-6 |
Pemigatinib
|
0 | C24H27F2N5O4 | |
GC32915-5mg |
|
1513857-77-6 |
Pemigatinib
|
0 | C24H27F2N5O4 | |
GC32915-10mM(1mLinDMSO) |
|
1513857-77-6 |
Pemigatinib
|
0 | C24H27F2N5O4 | |
GC32914-25mg |
|
1638526-21-2 |
EMT inhibitor-1
|
0 | C12H12Cl2N2O2S | |
GC32914-10mg |
|
1638526-21-2 |
EMT inhibitor-1
|
0 | C12H12Cl2N2O2S | |
GC32914-5mg |
|
1638526-21-2 |
EMT inhibitor-1
|
0 | C12H12Cl2N2O2S | |
GC32914-10mM(1mLinDMSO) |
|
1638526-21-2 |
EMT inhibitor-1
|
0 | C12H12Cl2N2O2S | |
GC32913-5mg |
|
1374040-24-0 |
Furimazine (PBI 3939)
|
0 | C24H19N3O2 | |
GC32913-10mM(1mLinDMSO) |
|
1374040-24-0 |
Furimazine (PBI 3939)
|
0 | C24H19N3O2 | |
GC32912-100mg |
|
313526-24-8 |
IBR2
|
0 | C24H20N2O2S | |
GC32912-50mg |
|
313526-24-8 |
IBR2
|
0 | C24H20N2O2S | |
GC32912-10mg |
|
313526-24-8 |
IBR2
|
0 | C24H20N2O2S | |
GC32912-5mg |
|
313526-24-8 |
IBR2
|
0 | C24H20N2O2S | |
GC32912-10mM(1mLinDMSO) |
|
313526-24-8 |
IBR2
|
0 | C24H20N2O2S | |